Skip to main content
OpenTrials
Completed

NCT Number: NCT04316299

Acute Kidney Injury in Patients Hospitalized With COVID-19

The kidney may be affected in coronavirus-2019 disease (COVID-19). This study assessed the predictors and outcomes of acute kidney injury (AKI) among individuals with COVID-19.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • COVID-19 pneumonia patients diagnosed by WHO criteria

Exclusion criteria

  • Patients who were younger than 18 years,
  • Patients who had undergone renal replacement therapy (RRT) before admission,
  • Patients whose entire stay lasted for less than 48 hours.

Treatment and study plan

Primary outcomes

  1. Rate of Acute Kidney Injury

    Time frame: From date of admission until the date of discharge or death from any cause, up to 60 days

    the incidence of Acute Kidney Injury

Secondary outcomes

  1. Rate of Death

    Time frame: From date of admission until the date of death from any cause, up to 60 days

    death from any cause in the hospital

  2. the length of hospital stay

    Time frame: From date of admission until the date of discharge or death from any cause, up to 60 days

    days from admission to discharge or death

Sponsors and collaborators

Lead sponsor

Zhenhua Zen

Other

Registry information

Official study title

Acute Kidney Injury in Patients Hospitalized With COVID-19 in Wuhan, China: a Single-center Retrospective Observational Study

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Mar 20, 2020
Registry last updated
Mar 30, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.